journal article·2018

AMF responsive DOX-loaded magnetic microspheres: transmembrane drug release mechanism and multimodality postsurgical treatment of breast cancer

Weiming Xue, Xiao-Li Liu, Heping Ma, Wensheng Xie, Saipeng Huang, Huiyun Wen, Guangyin Jing, Lingyun Zhao, Xing-Jie Liang, Hai Ming Fan

Journal of Materials Chemistry B· Volume 6· Issue 15
Publisher page

Abstract

DOX-loaded magnetic alginate-chitosan microspheres (DM-ACMSs) were developed as a model system to evaluate alternating magnetic field (AMF)-responsive, chemo-thermal synergistic therapy for multimodality postsurgical treatment of breast cancer. This multimodality function can be achieved by the combination of DOX for chemotherapy, with superparamagnetic iron oxide nanoparticles (SPIONs) as magnetic hyperthermia agents and drug release trigger. Both moieties are encapsulated in ACMSs which also allow on-demand drug release. It is demonstrated that the optimized SPION content in DM-ACMSs is about 0.29 mg Fe, at which DM-ACMSs could exhibit the best hyperthermia performance. Under a remote AMF, DM-ACMs can quickly reach a 22.5% cumulative drug release in the tumor site within 10 min upon exposure under AMF, whereas only 0.2% DOX is released in the absence of AMF. Furthermore, a comparison study of AMF and water bath as heating source indicates that the cumulative drug release amount upon AMF exposure is twice that by water bath heating. Further analysis revealed that the AMF stimulated drug release is driven by both thermal and concentration gradient from inside to outside, which can be well-described by the coupling mechanism of mass and heat transfer using the Soret diffusion model. In vitro cytotoxicity tests on MCF-7 breast cancer cells show that the combined therapy based on DM-ACMSs leads to 95.5% cell death, about 1.5-fold and 1.1-fold higher than that of single magnetic hyperthermia or chemotherapy, respectively. The in vivo anti-tumor effect on tumor-bearing mice demonstrates that the residual tumor disappears in 12 days after chemo-thermal synergistic treatment using DM-ACMSs, and there is no recurrence in the entire experiment period (40 days) as compared to 25 days recurrence for single-modality treatment. Our results not only provide an innovative DM-ACMSs system as a stimuli-responsive, synergistic chemo-thermal therapy platform for efficient reduction in the recurrence of breast cancer, but also provide insight into the intricate interplay of the functional components in magnetic hydrogel microspheres.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Characterization and Applications of Magnetic Nanoparticles

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemical Engineering

Northwest University

Xi’an

People's Republic of China

Key Laboratory of Synthetic and Natural Functional Molecule Chemistry of the Ministry of Education

College of Chemistry and Materials Science

State Key Laboratory of New Ceramics and Fine Processing

Key Laboratory of Advanced Materials

School of Material Science & Engineering

Tsinghua University

Beijing

Department of Physics

State Key Lab Incubation Base of Photoelectric Technology and Functional Materials

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety

National Center for Nanoscience and Technology

Funding

National Natural Science Foundation of China · China Postdoctoral Science Foundation

References (61)

Show source-provided references
1. Kamangar · J. Clin. Oncol. · 2006 · 24 · 213710.1200/JCO.2005.05.2308 ↗
2. Kohler · J. Natl. Cancer Inst. · 2015 · 107 · djv04810.1093/jnci/djv048 ↗
3. Carey · J. Am. Med. Assoc. · 2006 · 295 · 249210.1001/jama.295.21.2492 ↗
4. Ozmen · Meme. Sagligi. Dergisi. · 2008 · 4 · 2
5. Meyns · Rev. Med. Liege · 2006 · 61 · 623
7. Borger · J. Clin. Oncol. · 1994 · 12 · 65310.1200/JCO.1994.12.4.653 ↗
8. Francis · Br. J. Surg. · 1999 · 86 · 155610.1046/j.1365-2168.1999.01252.x ↗
9. Voogd · J. Clin. Oncol. · 2001 · 19 · 168810.1200/JCO.2001.19.6.1688 ↗
10. Conde · Nat. Mater. · 2016 · 15 · 112810.1038/nmat4707 ↗
11. Han · Cancer Biol. Ther. · 2011 · 11 · 83910.4161/cbt.11.9.15185 ↗
12. Lei · Nanoscale · 2012 · 4 · 568610.1039/c2nr30731f ↗
13. Kajjari · AAPS PharmSciTech · 2012 · 13 · 114710.1208/s12249-012-9838-8 ↗
14. Mi · Biomaterials · 2012 · 33 · 751910.1016/j.biomaterials.2012.06.100 ↗
15. Chen · Biomaterials · 2016 · 81 · 110.1016/j.biomaterials.2015.12.006 ↗
16. Kong · Nano Lett. · 2010 · 10 · 508810.1021/nl1033733 ↗
17. Hoare · Nano Lett. · 2009 · 9 · 365110.1021/nl9018935 ↗
18. Thomas · J. Am. Chem. Soc. · 2010 · 132 · 1062310.1021/ja1022267 ↗
19. Li · Biomaterials · 2015 · 51 · 1210.1016/j.biomaterials.2015.01.074 ↗
20. Brule · Adv. Mater. · 2011 · 23 · 78710.1002/adma.201003763 ↗
21. Chen · J. Mater. Chem. B · 2014 · 2 · 339110.1039/C4TB00069B ↗
22. Chang · J. Mater. Chem. · 2011 · 21 · 923910.1039/c1jm10631g ↗
23. Hervault · Nanoscale · 2014 · 6 · 1155310.1039/C4NR03482A ↗
24. Wu · Nano Lett. · 2012 · 12 · 547510.1021/nl301865c ↗
25. Hayashi · Adv. Funct. Mater. · 2016 · 26 · 170810.1002/adfm.201504215 ↗
26. Lei · Ceram. Int. · 2016 · 42 · 1779810.1016/j.ceramint.2016.08.108 ↗
27. Wee · Adv. Drug Delivery Rev. · 1998 · 31 · 26710.1016/S0169-409X(97)00124-5 ↗
28. Hu · Macromolecules · 2007 · 40 · 678610.1021/ma0707584 ↗
29. Frimpomg · Nanotechnology · 2008 · 19 · 17510110.1088/0957-4484/19/17/175101 ↗
30. Kost · J. Biomed. Mater. Res. · 1987 · 211367
31. Paoli · Langmuir · 2006 · 22 · 589410.1021/la060280h ↗
32. Liu · J. Controlled Release · 2008 · 126 · 22810.1016/j.jconrel.2007.12.006 ↗
33. Lu · Langmuir · 2005 · 21 · 204210.1021/la047629q ↗
34. Derfus · Adv. Mater. · 2007 · 19 · 393210.1002/adma.200700091 ↗
35. Satarkar · J. Controlled Release · 2008 · 130 · 24610.1016/j.jconrel.2008.06.008 ↗
36. Cuomo · Langmuir · 2014 · 30 · 799310.1021/la501978u ↗
37. Lacerda · Mater. Sci. Eng., C · 2014 · 39 · 16110.1016/j.msec.2014.01.054 ↗
38. Azhar · Appl. Clay Sci. · 2014 · 101 · 28810.1016/j.clay.2014.09.004 ↗
39. Illum · Pharm. Res. · 1994 · 11 · 118610.1023/A:1018901302450 ↗
40. Wang · J. Mater. Chem. · 2006 · 16 · 325210.1039/b603595g ↗
41. Rosensweig · J. Magn. Magn. Mater. · 2002 · 252 · 37010.1016/S0304-8853(02)00706-0 ↗
42. Liu · Chem. Soc. Rev. · 2014 · 43 · 809810.1039/C4CS00162A ↗
43. Thomas · J. Mater. Chem. · 2009 · 19 · 652910.1039/b908187a ↗
44. Ho · Acc. Chem. Res. · 2011 · 44 · 87510.1021/ar200090c ↗
45. Lacroix · Rev. Sci. Instrum. · 2008 · 79 · 09390910.1063/1.2972172 ↗
46. Carrey · J. Appl. Phys. · 2011 · 109 · 08392110.1063/1.3551582 ↗
47. Yu · J. Membr. Sci. · 2011 · 377 · 21410.1016/j.memsci.2011.04.053 ↗
48. Feng · ACS Appl. Mater. Interfaces · 2014 · 6 · 844710.1021/am501337s ↗
49. Tao · ACS Nano · 2010 · 4 · 78910.1021/nn9015345 ↗
50. Tao · Int. J. Pharm. · 2007 · 336 · 37610.1016/j.ijpharm.2006.12.009 ↗
51. Liu · J. Mater. Chem. B · 2014 · 2 · 12010.1039/C3TB21146K ↗
52. Brazel · Pharm. Res. · 2009 · 26 · 64410.1007/s11095-008-9773-2 ↗
53. Grull · J. Controlled Release · 2012 · 161 · 31710.1016/j.jconrel.2012.04.041 ↗
54. Hayashi · ACS Appl. Mater. Interfaces · 2010 · 2 · 190310.1021/am100237p ↗
55. Groot · Physica · 1942 · 9 · 69910.1016/S0031-8914(42)80036-1 ↗
56. Bierlein · J. Chem. Phys. · 1955 · 23 · 1010.1063/1.1740504 ↗
57. Choudhury · Int. J. Pharm. · 2014 · 460 · 13110.1016/j.ijpharm.2013.10.055 ↗
58. Park · Nat. Mater. · 2004 · 3 · 89110.1038/nmat1251 ↗
59. Sun · J. Am. Chem. Soc. · 2004 · 126 · 27310.1021/ja0380852 ↗
60. Wang · J. Nanosci. Nanotechnol. · 2011 · 11 · 368810.1166/jnn.2011.3751 ↗
61. Tomayko · Cancer Chemother. Pharmacol. · 1989 · 24 · 14810.1007/BF00300234 ↗